|
FOXK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.96240032504613E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.62149999485928E-08 |
| Normal-vs-Stage2 |
2.08940000001601E-06 |
| Normal-vs-Stage3 |
3.09250003382999E-09 |
| Normal-vs-Stage4 |
5.567399999995E-05 |
| Stage1-vs-Stage2 |
2.747000E-01 |
| Stage1-vs-Stage3 |
5.235600E-02 |
| Stage1-vs-Stage4 |
9.715200E-01 |
| Stage2-vs-Stage3 |
7.370600E-01 |
| Stage2-vs-Stage4 |
4.101200E-01 |
| Stage3-vs-Stage4 |
1.739190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73929759483826E-11 |
| Normal-vs-AfricanAmerican |
3.652100E-02 |
| Normal-vs-Asian |
6.235000E-01 |
| Caucasian-vs-AfricanAmerican |
9.571600E-04 |
| Caucasian-vs-Asian |
5.967500E-02 |
| AfricanAmerican-vs-Asian |
6.039400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.85209633688055E-11 |
| Normal-vs-Female |
4.31059999994599E-06 |
| Male-vs-Female |
5.044800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.239800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.99690000488329E-09 |
| Normal-vs-Age(61-80Yrs) |
1.99759999652827E-08 |
| Normal-vs-Age(81-100Yrs) |
3.045500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.574200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.014000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.708000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.119400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.441600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.373800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.317400E-01 |
| Normal-vs-Grade 2 |
3.91029999491366E-08 |
| Normal-vs-Grade 3 |
1.64720004303121E-09 |
| Normal-vs-Grade 4 |
2.002200E-03 |
| Grade 1-vs-Grade 2 |
1.643010E-01 |
| Grade 1-vs-Grade 3 |
2.277800E-02 |
| Grade 1-vs-Grade 4 |
5.079200E-01 |
| Grade 2-vs-Grade 3 |
4.848200E-02 |
| Grade 2-vs-Grade 4 |
3.766000E-01 |
| Grade 3-vs-Grade 4 |
4.545800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.65150001954595E-09 |
| Normal-vs-ccB subtype |
3.51170000000289E-05 |
| ccA subtype-vs-ccB subtype |
8.114200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.43360015367489E-10 |
| Normal-vs-N1 |
5.862800E-01 |
| N0-vs-N1 |
1.766030E-01 |
|
|
